Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Conditions

• Lung Cancer

Interventions

• DRUG: docetaxel
• DRUG: erlotinib hydrochloride
• DRUG: pemetrexed disodium
• GENETIC: fluorescence in situ hybridization
• GENETIC: mutation analysis
• GENETIC: proteomic profiling
• OTHER: immunohistochemistry staining method
• OTHER: laboratory biomarker analysis
• OTHER: matrix-assisted laser desorption/ionization time of flight mass spectrometry
• PROCEDURE: breath test

Sponsor

Istituto Scientifico H. San Raffaele